The Food and Drug Administration (FDA) has approved both Ozempic and Wegovy (semaglutide) to lower blood sugar, improve heart health, and support weight loss. Some differences set Ozempic and ...

Ozempic (semaglutide) and Wegovy (semaglutide) are brand-name injections. Ozempic is approved for type 2 diabetes, but doctors may sometimes prescribe it off-label for weight loss and management.

Semaglutide is available as Wegovy and Ozempic injections, and also as Rybelsus tablets. The study's findings indicate a potential link between these medications and a lower risk of dementia.

The use of weight loss treatments like Ozempic and Wegovy has skyrocketed in the Western world. But as more people turn to these treatments, which mimic the appetite-suppressing hormone GLP-1 ...

The Food and Drug Administration wants bulk production of the copycats to stop—starting Wednesday for pharmacy-prepared versions of Zepbound and later in the spring for knockoffs of Ozempic and ...

Semaglutide medications like Ozempic and Wegovy have exploded in popularity in recent years due to their effectiveness in diabetes control and weight loss. Research has revealed additional ...

John Fetterman (D-Pa.) on Wednesday called on the Trump administration to back a Biden-era rule that would expand access to GLP-1 medications, such as Ozempic and Wegovy, for millions of Medicare ...

AUSTIN (KXAN) — Affordable and alternative versions of popular weight loss drugs, like Ozempic and Wegovy, may no longer be available. The Food and Drug Administration (FDA) ordered compounding ...

States increasingly struggling to cover the rising cost of popular GLP-1 drugs like Wegovy, Ozempic and Zepbound are searching for ways to get out from under the budgetary squeeze that took them ...

SAO PAULO, April 7 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab, the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil to boost ...

Diabetes and weight loss treatments such as Ozempic and Wegovy, known as GLP-1 agonists, could significantly reduce the risk of developing any type of dementia, according to a meta-analysis of 26 ...

Affordable and alternative versions of popular weight loss drugs like Ozempic and Wegovy may no longer be available. The FDA ordered compounding pharmacies to stop making those versions after ...